Re: A new way to stave off recurrence? - Management of breast cancer based on CA27.29 and CA15.3


"J" <questra@xxxxxxxxxxxx> wrote in message
news:42D5653B.B52E44D9@xxxxxxxxxxxxxxxx
> Some, on the breast cancer newsgroup, seem to be using the above (markers)
> to base their treatments/changes decisions and they're quoting the
> following article.
>
> http://www.clinchem.org/cgi/content/full/45/5/630 Clinical Chemistry 45:
> 630-637, 1999;
>
> An example: "Diagnosed stage IV, 1999 with lung mets, she's healthy as a
> horse, her scans are clear; her chest x-ray is clear; her liver enzymes
> are fine, no sign of mets, but her markers are rising, on straight
> Herceptin, so we're back into round 3 of treatments. Both Navelbine and
> Taxotere have proven to be synergistic with Herceptin and this just might
> work"
>
> Comments?
> J
>

I've given my views on taking treatment because of rising markers many
times.


.

Relevant Pages
Quantcast